SCHEMBL17850586

SCHEMBL17850586

CCCN(CC)C(=O)CNC(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.40
CA12 O43570 3/20 0.36
CA9 Q16790 3/20 0.36
CA2 P00918 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 2/20 0.34
MAPK1 P28482 1/20 0.34
CYP2D6 P10635 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
LMNA P02545 1/20 0.33
CA1 P00915 2/20 0.32
KDM5B Q9UGL1 3/20 0.32
PYGL P06737 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN5 P54829 1/20 0.32
PTPN11 Q06124 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17850637 0.89 CA12 (0.46) EPHX1CA12CA9CA2ALDH1A1
SCHEMBL17850573 0.88 LMNA (0.43) EPHX1CA12CA9CA2ALDH1A1
SCHEMBL17850653 0.84 EPHX1 (0.49) EPHX1CA12CA9CA2ALDH1A1
SCHEMBL17850613 0.79 CA12 (0.38) CA12CA9CA2ALDH1A1HPGD
SCHEMBL24503915 0.76 CA12 (0.41) CA12CA9CA2ALDH1A1HPGD
SCHEMBL23801581 0.72 CA12 (0.42) CA12CA2ALDH1A1HPGDTSHR
SCHEMBL21716653 0.71 ALDH1A1 (0.42) CA12ALDH1A1TSHRCA1KDM5B
SCHEMBL13627778 0.71 EPHX1 (0.39) EPHX1ALDH1A1TSHRMAPK1HSD17B10
SCHEMBL6201216 0.71 CA12 (0.44) CA12CA9CA2ALDH1A1HPGD
SCHEMBL1375855 0.71 ALDH1A1 (0.48) CA12CA9CA2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2714036-B1 SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS ACHILLION PHARMACEUTICALS INC (US) 2016-06-22 EP disclosed